Naloxone Bioavailability

Naloxone Bioavailability is the proportion of an administered dose of naloxone that reaches the systemic circulation unchanged, serving as a pharmacokinetic metric to quantify the rate and extent of active drug absorption into the body.

22

Publications

1.7K

Citations

100

Authors

44

Institutions

Publications per year

2017–2026

10

Authors

100

  1. BJ
    Bruce J. Aungst

    DuPont (United States), United States

    2 publications · 348 citations

    2

    h-index

  2. RP
    Ramesh Panchagnula

    National Institute of Pharmaceutical Education and Research, India

    2 publications · 170 citations

    2

    h-index

  3. KJ
    Kevin J. Smith

    Mundipharma (United Kingdom), United Kingdom

    2 publications · 126 citations

    2

    h-index

  4. ES
    Eli Shefter

    University at Buffalo, State University of New York, United States

    2 publications · 348 citations

    2

    h-index

  5. PR
    Poduri Ramarao

    National Institute of Pharmaceutical Education and Research, India

    2 publications · 170 citations

    2

    h-index

1–5 of 100

Venues

  1. International Journal of Pharmaceutics

    4 publications · 518 citations

    4

    h-index

  2. Drug and Alcohol Dependence

    2 publications · 157 citations

    2

    h-index

  3. Journal of the American Pharmacists Association

    JAPhA · 2 publications · 66 citations

    2

    h-index

  4. Journal of Pharmaceutical Sciences

    1 publications · 40 citations

    1

    h-index

  5. 1

    h-index

1–5